Bioray Biotech Co (ROCO:7561) Construction In Progress: NT$0.0 Mil (As of Dec. 2025)


ROCO:7561 Bioray Biotech Co Ltd ROCO:7561
82 GF Score
Price NT$18.85
GF Value NT$29.48
Valuation Significantly Undervalued
View Full Analysis

What is Bioray Biotech Co Construction In Progress?

Bioray Biotech Co ROCO:7561 +4.43% 82 Construction In Progress is NT$0.0 Mil as of Dec. 2025. GuruFocus rates ROCO:7561 with a GF Score™ of 82/100 and a GF Value™ of NT$29.48 (Significantly Undervalued).

Bioray Biotech Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Bioray Biotech Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioray Biotech Co Construction In Progress Chart

Bioray Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only 1.54 0.04 0.00 0.00 0.00

Bioray Biotech Co Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:7561
82GF Score
Bioray Biotech Co Ltd ROCO:7561
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioray Biotech Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of NT$0.0 Mil mean?
Bioray Biotech Co (ROCO:7561) has a Construction In Progress of NT$0.0 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Bioray Biotech Co and its competitors.
Is Bioray Biotech Co's Construction In Progress too high?
Bioray Biotech Co's current Construction In Progress is NT$0.0 Mil. Overall, Bioray Biotech Co has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioray Biotech Co's Construction In Progress compare to ZTS and UTHR?
Bioray Biotech Co's Construction In Progress of NT$0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Bioray Biotech Co and its competitors. Bioray Biotech Co's current Construction In Progress is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioray Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Bioray Biotech Co (ROCO:7561) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$29.48, compared to a current price of NT$18.85 — trading 36.1% below its estimated fair value. The current Construction In Progress is NT$0.0 Mil. Bioray Biotech Co's overall GF Score™ is 82/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Bioray Biotech Co (ROCO:7561), the current Construction In Progress is NT$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioray Biotech Co (ROCO:7561) Overvalued in 2026?

Based on GuruFocus' analysis, Bioray Biotech Co stock appears to be undervalued. The current stock price of NT$18.85 is trading 36.1% below its estimated GF Value™ of NT$29.48. GuruFocus considers Bioray Biotech Co to be Significantly Undervalued.

Key valuation signals for ROCO:7561:

  • Construction In Progress: NT$0.0 Mil
  • GF Value™: NT$29.48 vs. price of NT$18.85 (36.1% below fair value)
  • GF Score™: 82/100

No single metric tells the full story. See the ROCO:7561 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioray Biotech Co Business Description

Address No. 1, Dali 2nd Road, Southern Science Park, Shanhua District, Tainan, TWN, 90846
Bioray Biotech Co Ltd is engaged in the development and manufacturing of biological agents, including functional probiotics, medicinal fungi, and immune cell preparations.
82GF Score

Get the complete analysis for ROCO:7561

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.85
Price
NT$29.48
GF Value